AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
Tax period
2011-06-01 to 2012-05-31
Filed
2013-04-04
IRS object ID
201340949349300709
Schema version
2011v1.5
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-04-04T11:43:37-05:00Timestamp
Tax Period End Date2012-05-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN521855942EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1TATE AND TRYONBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line12021 L STREET NW SUITE 400AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20036ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-06-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN237033369EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1AMERICAN SOCIETY OF HEALTH-SYSTEMBusinessNameLine1
Business Name Line2PHARMACISTS RESEARCH AND EDUCATION FDTNBusinessNameLine2
FieldValueIRS element (for citing)
Name ControlAMERNameControl
Phone3016648612Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameSTEPHEN J ALLENName
TitleEXECUTIVE VICE PRESIDENT AND CEOTitle
Phone3016648612Phone
Date Signed2013-04-04DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameDEBORAH G KOSNETTName
PTINP00290720PTIN
Phone2022932200Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-25 16:41:14ZBuildTS

Form 990 IRS990

Doing Business As DoingBusinessAs

FieldValueIRS element (for citing)
Business Name Line1ASHP FOUNDATIONBusinessNameLine1
FieldValueIRS element (for citing)
Name Of Principal Officer PersonSTEPHEN J ALLENNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode
FieldValueIRS element (for citing)
Gross Receipts6076786GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.ASHPFOUNDATION.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1968YearFormation
State Legal DomicileMDStateLegalDomicile
Activity Or Mission DescriptionTHE MISSION OF THE ASHP FOUNDATION IS TO IMPROVE THE HEALTH AND WELL-BEING OF PATIENTS IN HEALTH SYSTEMS THROUGH APPROPRIATE, SAFE AND EFFECTIVE MEDICATION USE.ActivityOrMissionDescription
Nbr Voting Members Governing Body12NbrVotingMembersGoverningBody
Nbr Independent Voting Members10NbrIndependentVotingMembers
Total Nbr Employees0TotalNbrEmployees
Total Nbr Volunteers100TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year2697502ContributionsGrantsPriorYear
Contributions Grants Current Year3023671ContributionsGrantsCurrentYear
Program Service Revenue Prior Year216540ProgramServiceRevenuePriorYear
Program Service Revenue CY283495ProgramServiceRevenueCY
Investment Income Prior Year1315173InvestmentIncomePriorYear
Investment Income Current Year36555InvestmentIncomeCurrentYear
Other Revenue Prior Year-7191OtherRevenuePriorYear
Other Revenue Current Year-10941OtherRevenueCurrentYear
Total Revenue Prior Year4222024TotalRevenuePriorYear
Total Revenue Current Year3332780TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year349477GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY1369149GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year1178599SalariesEtcPriorYear
Salaries Etc Current Year1249172SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year490413TotalFundrsngExpCurrentYear
Other Expense Prior Year1161985OtherExpensePriorYear
Other Expenses Current Year1145160OtherExpensesCurrentYear
Total Expenses Prior Year2690061TotalExpensesPriorYear
Total Expenses Current Year3763481TotalExpensesCurrentYear
Revenues Less Expenses Prior Year1531963RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-430701RevenuesLessExpensesCY
Total Assets BOY11482201TotalAssetsBOY
Total Assets EOY10865231TotalAssetsEOY
Total Liabilities BOY389691TotalLiabilitiesBOY
Total Liabilities EOY439943TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY11092510NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY10425288NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionOUR MISSION:THE MISSION OF THE ASHP FOUNDATION IS TO IMPROVE THE HEALTH AND WELL-BEING OF PATIENTS IN HEALTH SYSTEMS THROUGH APPROPRIATE, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, OUR VISION IS THAT: PATIENT OUTCOMES IMPROVE BECAUSE OF THE LEADERSHIP AND CLINICAL SKILLS OF PHARMACISTS, AS VITAL MEMBERS OF THE HEALTH CARE TEAM, ACCOUNTABLE FOR SAFE AND EFFECTIVE MEDICATION USE.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense2132193Expense
Grants1314308Grants
DescriptionADVANCING PATIENT CARE THROUGH PRACTICE TRANSFORMATIONAWARDS PROGRAMS:ASHP STUDENT LEADERSHIP AWARD- THIS PROGRAM, FUNDED THROUGH THE WALTER JONES MEMORIAL PHARMACY STUDENT FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE AND OUTSTANDING LEADERSHIP SKILLS ARE RECOGNIZED. FOUR STUDENTS ARE SELECTED FROM REPRESENTATIVES OF THE P2 THROUGH P4 CLASSES. 2011 RECIPIENTS INCLUDED: 2012 CLASS - EUNICE K. RHEE (UNIVERSITY OF SOUTHERN CALIFORNIA SCHOOL OF PHARMACY), KENNETH W. WORSHAM, II (HAMPTON UNIVERSITY SCHOOL OF PHARMACY), KRYSTAL CANALLY (THE OHIO STATE UNIVERSITY COLLEGE OF PHARMACY), AND RYAN C. COSTANTINO (MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES); 2013 CLASS - CALVIN J. ICE (OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY), CASEY M. COMBS (UNIVERSITY OF KENTUCKY COLLEGE OF PHARMACY), CATHERINE K. FLOROFF (VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY), MELISSA C. ERIN (UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS SKAGGS SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES), AND PHUOC ANH (ANNE) NGUYEN (UNIVERSITY OF TEXAS AT AUSTIN COLLEGE OF PHARMACY); AND 2014 CLASS - BRADY T. MCNULTY (TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER IRMA LERMA RANGEL COLLEGE OF PHARMACY), MOLLY C. TRAYAH (ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES), AND TOLULOPE E. AKINBO (LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE SCHOOL OF PHARMACY). THE AWARDEES RECEIVED A PLAQUE, A $2,500 AWARD AND A DRUG INFORMATION LIBRARY CONSISTING OF 10 ASHP PUBLICATIONS. AWARD FOR EXCELLENCE IN MEDICATION-USE SAFETY-SUPPORTED BY A GRANT FROM THE CARDINAL HEALTH FOUNDATION, THIS PROGRAM IS DESIGNED TO RECOGNIZE A PHARMACIST-LED MULTIDISCIPLINARY TEAM THAT MAKES SIGNIFICANT INSTITUTION-WIDE SYSTEM IMPROVEMENTS RELATING TO MEDICATION USE. THE PROGRAM IS IN ITS EIGHTH YEAR AND IS THE ONLY NATIONAL-LEVEL PROGRAM THAT RECOGNIZES THE PHARMACIST'S LEADERSHIP ROLE IN THE MEDICATION-USE PROCESS. THE 2011 RECIPIENT AND FINALIST ORGANIZATIONS WERE SELECTED FROM 48 APPLICANTS USING STRUCTURED SELECTION CRITERIA ESTABLISHED BY AN INDEPENDENT MULTIDISCIPLINARY PANEL OF EXPERTS IN THE FIELD OF MEDICATION SAFETY AND HEALTH-SYSTEM ADMINISTRATION. UW HEALTH IN MADISON, WI WAS THE RECIPIENT ORGANIZATION AND RECEIVED A $50,000 AWARD FOR ITS ANTICOAGULATION STEWARDSHIP PROGRAM. THE TWO FINALISTS, KAISER PERMANENTE COLORADO IN DENVER, CO AND THE UNIVERSITY OF MICHIGAN HEALTH SYSTEM IN ANN ARBOR, MI, EACH RECEIVED $10,000 FOR THEIR RESPECTIVE PROGRAMS, THE DRUG RENAL ALERT PHARMACY (DRAP) PROGRAM: IMPROVING PRESCRIBING SAFETY IN PATIENTS WITH RENAL INSUFFICIENCY IN THE AMBULATORY SETTING AND ELEVATING PAIN MANAGEMENT STRATEGIES TO IMPROVE PATIENT OUTCOMES. THE 2011 AWARD FOR EXCELLENCE VIDEO HIGHLIGHTED THE SUCCESS STORIES OF THE RECIPIENT AND FINALISTS AND WAS SHOWN TO MORE THAN 7,000 PHARMACISTS AT THE 2011 ASHP MIDYEAR CLINICAL MEETING OPENING GENERAL SESSION IN NEW ORLEANS, LA. A DINNER WAS ALSO HELD AT THE MIDYEAR TO RECOGNIZE THE FINALIST AND RECIPIENT TEAMS.FOR THE FIFTH CONSECUTIVE YEAR, THE ASHP FOUNDATION, WITH ASSISTANCE FROM ASHP, SPONSORED A NATIONAL RADIO MEDIA TOUR AIMED AT EDUCATING CONSUMERS ABOUT THE VITAL ROLE OF HEALTH-SYSTEM PHARMACISTS. THE RADIO MEDIA TOUR OCCURRED IN MARCH 2012 DURING NATIONAL PATIENT SAFETY AWARENESS WEEK. FOR THE TOUR, THERE WERE 6 LIVE AND 12 TAPED INTERVIEWS, WHICH REACHED 5.2 MILLION LISTENERS. DR. ANNE ROSE ALSO TAPED A RADIO NEWS RELEASE FOR NATIONAL PATIENT SAFETY AWARENESS WEEK THAT WAS AIRED BY APPROXIMATELY 779 STATIONS AND WAS HEARD BY 2.7 MILLION LISTENERS. IN ADDITION, DRS. ANNE ROSE, PHILIP J. TRAPSKIN AND JOHN R. HOCH PRESENTED AN EDUCATIONAL SESSION AT THE 2012 ASHP SUMMER MEETING ENTITLED "ANTICOAGULATION STEWARDSHIP IMPROVING PATIENT CARE ACROSS A HEALTH-SYSTEM."IN AUGUST 2011, THE ASHP FOUNDATION RECEIVED SUPPORT FROM THE CARDINAL HEALTH FOUNDATION TO CONTINUE THE PROGRAM IN 2012 AND 2013. THE 2012 AWARD PROGRAM WAS MODIFIED TO INCLUDE A LETTER-OF-INTENT PROCESS AND WAS LAUNCHED IN EARLY SPRING 2012. SIXTY-FOUR APPLICATIONS WERE RECEIVED AND THE RECIPIENT AND FINALISTS WERE SELECTED IN JULY 2012.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM-THE 2011 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED BY AMGEN, INC. THIS UNIQUE NATIONAL COMPETITION RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS, AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM CONSISTS OF THE PRECEPTOR AWARD, NEW PRECEPTOR AWARD AND PROGRAM AWARD. TWENTY APPLICATIONS WERE RECEIVED FOR THE 2011 PROGRAM AND THE RECIPIENTS WERE: PRECEPTOR AWARD: MARGARET M. CHRYMKO, B.S., M.A., PHARM.D., FASHP, EERIE VETERANS AFFAIRS MEDICAL CENTER; NEW PRECEPTOR AWARD: DOROTHY MCCOY, , PHARM.D., BCPS, AQ-ID, HACKENSACK UNIVERSITY MEDICAL CENTER; AND PROGRAM AWARD: UNIVERSITY OF UTAH HOSPITALS AND CLINICS POST-GRADUATE YEAR 1RESIDENCY PROGRAM. SUPPORT WAS RECEIVED FROM AMGEN TO HOST THIS PROGRAM AGAIN IN 2012. PROGRAM APPLICATION MATERIALS WERE REVISED AND MADE AVAILABLE IN MARCH 2012 FOR A JUNE 22, 2012, DEADLINE. LITERATURE AWARDS PROGRAM-THE ASHP FOUNDATION LITERATURE AWARDS PROGRAM ANNUALLY RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, IS BASED ON THE CONCEPT THAT RECOGNITION THROUGH AWARDS STIMULATES RESEARCH AND INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE PROFESSIONAL LITERATURE. SIXTY-THREE APPLICATIONS WERE RECEIVED FOR THE 2011 PROGRAM. RECIPIENTS WERE: AWARD FOR SUSTAINED CONTRIBUTIONS TO THE LITERATURE: CHRISTINE A. SORKNESS, PHARM.D., UNIVERSITY OF WISCONSIN SCHOOL OF PHARMACY; AWARD FOR INNOVATION IN PHARMACY PRACTICE: MARIE A. SMITH, PHARM.D., UNIVERSITY OF CONNECTICUT; DRUG THERAPY RESEARCH AWARD: RHONDA M. COOPER-DEHOFF, PHARM.D., M.S., UNIVERSITY OF FLORIDA; PHARMACY PRACTICE RESEARCH AWARD: MARIE A. CHISHOLM-BURNS, PHARM.D., M.P.H., UNIVERSITY OF ARIZONA; AND STUDENT RESEARCH AWARD: MICHAEL L. SPINNER, PHARM.D., ST. LOUIS COLLEGE OF PHARMACY. AWARDEES WERE HONORED AT A BREAKFAST RECEPTION AT THE 2011 MIDYEAR CLINICAL MEETING. ASHP DUES CONTRIBUTIONS SUPPORT THIS PROGRAM. EDUCATION PROGRAMS:- ONCOLOGY PATIENT CARE TRAINEESHIP - CRITICAL CARE TRAINEESHIP - PAIN AND PALLIATIVE CARE TRAINEESHIP - PHARMACY RESIDENCY EXPANSION GRANT- PHARMACY STUDENT CLINICAL SKILLS COMPETITIONRESEARCH PROGRAMS:- AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP - MEDICATION CONTINUITY OF CARE RECORD RESEARCH - MEDICATION SAFETY TEAM GRANT: OPTIMIZING BEDSIDE TECHNOLOGY SOLUTIONS - MULTICENTER MEDICATION RECONCILIATION QUALITY IMPROVEMENT STUDY (MARQUIS) - NEW INVESTIGATOR RESEARCH GRANT - PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM - PROMOTING INFLUENZA PREVENTION: PHARMACISTS AS IMMUNIZATION ADVOCATES - PHARMACY PRACTICE MODEL INITIATIVE DEMONSTRATION GRANTS- RESEARCH BOOT CAMP - RESEARCH ADVISORY PANEL- UNIVERSITY OF ALABAMA MUSCULOSKELETAL CERTS - UNSOLICITED GRANTTOOLS AND RESOURCES:- DRUG THERAPY MANAGEMENT COMPLEXITY SCORE- HARVEY A. K. WHITNEY AWARD LECTURE S ONLINE COLLECTION PROGRAM- INSULIN-USE SAFETY- STERILE PRODUCTS OUTSOURCING TOOLDescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense972112Expense
Grants54840Grants
Revenue283495Revenue
DescriptionADVANCING PATIENT CARE THROUGH PHARMACIST LEADERSHIPLEADERSHIP PROGRAMS:CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP-THE CENTER, DEVELOPED AS A COLLABORATIVE PROGRAMMATIC OFFERING OF ASHP AND THE ASHP FOUNDATION, ENTERED ITS 6TH YEAR OF BEING ADMINISTERED BY THE FOUNDATION. ITS PRIMARY OBJECTIVES ARE TO: (1) ASSURE THAT PHARMACY LEADERS HAVE THE KNOWLEDGE NECESSARY TO PROACTIVELY INFLUENCE THE ADVANCEMENT OF THE MEDICATION-USE PROCESS BY PROVIDING COMPETENCY-BASED EDUCATION OPPORTUNITIES, (2) PROVIDE LEADERSHIP DEVELOPMENT PROGRAMS FOR STUDENTS, RESIDENTS AND NEW PRACTITIONERS THAT PROMOTE THE IMPORTANT ROLE OF THE PHARMACIST AS A CHANGE AGENT AND A LEADER IN PATIENT CARE, (3) INTEGRATE INTO HEALTH-SYSTEM LEADERSHIP DECISION-MAKING THE CRITICAL ROLE FOR PHARMACISTS AS ACTIVE PARTICIPANTS IN ACHIEVING ORGANIZATIONAL OBJECTIVES, AND (4) CONDUCT RESEARCH ON EFFECTIVE PHARMACY MANAGEMENT AND LEADERSHIP IN ACHIEVING THE OBJECTIVES OF HOSPITALS AND HEALTH SYSTEMS, AS WELL AS IMPROVING COMMUNITY DISEASE PREVENTION AND HEALTH PROMOTION EFFORTS. PHARMACY FORECAST PROJECT-THIS PROJECT IS THE FIRST PROGRAM OFFERING SUPPORTED BY THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND. THE PURPOSE OF THIS PROJECT IS TO IMPROVE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY BY PROVIDING A VIEW OF IMPORTANT FUTURE TRENDS IN EIGHT KEY DOMAIN AREAS. DOMAINS WERE IDENTIFIED BY AN ADVISORY GROUP BY VIRTUE OF THEIR PROJECTED LIKELIHOOD TO CHALLENGE PHARMACY LEADERS IN THE NEXT FIVE YEARS. THE REPORT, SCHEDULED TO BE RELEASED AT THE 2012 ASHP MIDYEAR CLINICAL MEETING, WILL PROVIDE STRATEGIC GUIDANCE IN THE FOLLOWING AREAS: PHARMACY PRACTICE MODELS; PHARMACY WORKFORCE; TECHNOLOGY, HEALTHCARE DELIVERY & FINANCING; DRUG DEVELOPMENT AND THERAPEUTICS; PHARMACEUTICAL MARKETPLACE; PHYSICIAN AND NURSE WORKFORCES; AND CONSUMER HEALTHCARE SERVICES. PHARMACY LEADERSHIP ACADEMY (PLA)- THE PLA, SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN, IS DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP TRAINING TO PHARMACISTS. THE ACADEMY PROVIDES LEADERSHIP TRAINING APPLICABLE TO ALL PHARMACY PRACTITIONERS IN SMALL TO LARGE HOSPITALS AND HEALTH SYSTEMS WHO ASPIRE TO LEADERSHIP POSITIONS IN HEALTH-SYSTEM PHARMACY. MOST IMPORTANTLY, THIS PROGRAM DIRECTLY BENEFITS PATIENTS BECAUSE PARTICIPANTS APPLY THEIR NEW-FOUND SKILLS IN THE HEALTH-SYSTEM ENVIRONMENT TO IMPROVE MEDICATION-USE SAFETY, QUALITY OF CARE AND USE OF HEALTH CARE RESOURCES. STARTING IN 2011 THE PLA WAS ELEVATED TO A GRADUATE CREDIT WORTHY PROGRAM OFFERING ACADEMY PARTICIPANTS THE OPPORTUNITY TO CONTINUE THEIR ACADEMIC PURSUIT. FIFTY-TWO PHARMACISTS ARE PURSUING GRADUATE DEGREES ASSOCIATED WITH THE ACADEMY. THE FIFTH CLASS BEGAN IN JANUARY 2012 WITH 57 PARTICIPANTS. PFIZER, THROUGH A DONATION TO THE ZILZ LEADERS FOR THE FUTURE FUND, SUPPORTED SIX INTERNATIONAL SCHOLARSHIPS, WHICH ACCOUNTED FOR A TOTAL OF 13 INTERNATIONAL PARTICIPANTS IN THE 2012 CLASS; ONE FROM THE CANADA, FOUR FROM KENYA, TWO FROM NIGERIA, ONE FROM PORTUGAL, THREE FROM SAUDI ARABIA, AND TWO FROM THE UNITED ARAB EMIRATES. EMERGING LEADERS SESSION FOR PHARMACY ADMINISTRATIVE RESIDENTS AT THE ASHP LEADERS CONFERENCE-"EMOTIONAL AND BEHAVIORAL INTELLIGENCE: LEADING TEAMS BY UNDERSTANDING THE HUMAN FACTOR" WAS CONDUCTED ON SUNDAY EVENING, OCTOBER 16, 2011, PRIOR TO THE SIXTEENTH ANNUAL ASHP CONFERENCE FOR LEADERS IN HEALTH-SYSTEM PHARMACY. THIS ACTIVITY WAS PLANNED BY THE ASHP SECTION OF PHARMACY PRACTICE MANAGERS AND THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP, CONDUCTED BY ASHP ADVANTAGE, AND SPONSORED BY PFIZER, INC. THE THREE-HOUR EVENING PROGRAM WAS ATTENDED BY AN ESTIMATED 100 PHARMACY ADMINISTRATIVE RESIDENTS AND THEIR PRECEPTORS. PHARMACY LEADERSHIP INSTITUTE (PLI)-ASHP AND ASHP FOUNDATION ENTERED ITS 13TH YEAR OF THE PLI THROUGH COLLABORATION WITH BOSTON UNIVERSITY AS A MAJOR PROGRAM WITHIN THE CENTER'S PORTFOLIO. THE PLI USES RELEVANT PROGRAM CURRICULUM, HIGH-QUALITY INSTRUCTION AND PEER INTERACTION TO BROADEN BUSINESS SKILLS, MANAGERIAL VERSATILITY AND THE EXTRAORDINARY LEADERSHIP DEMANDED OF TODAY'S HEALTH-SYSTEM PHARMACY LEADERS. THE EXPERIENCE ENABLES PHARMACIST LEADERS TO DEVELOP A NEW WAY OF THINKING AND A NEW SET OF BEHAVIORS TO MEET THE DEMANDING CHALLENGES FACING PHARMACY. PLI GRADUATES HAVE BECOME A SOURCE OF LEADERSHIP EXPERTS SERVING THE CENTER'S INITIATIVES. THE PLI ALUMNI, NOW 320 STRONG, ARE A VALUABLE ASSET FOR THE CENTER SERVING TO PROMOTE ITS PROGRAMS AND OFFER THEIR ASSISTANCE AS APPLICATION REVIEWERS. THIRTY PHARMACY LEADERS WERE SELECTED TO ATTEND THE 1-WEEK EXECUTIVE TRAINING PROGRAM APRIL 29-MAY 4, 2012. CONVERSATIONS WITH HEALTH-SYSTEM PHARMACY'S MOST INFLUENTIAL LEADERS VIDEOS-ASHP PAST PRESIDENT AND WHITNEY AWARD RECIPIENT SARA WHITE PROVIDED THE FOUNDATION WITH ONGOING FINANCIAL SUPPORT AND VOLUNTEERED HER TIME TO HELP PRODUCE A SERIES OF VIDEOS WITH SOME OF THE MOST INFLUENTIAL HEALTH-SYSTEM PHARMACY LEADERS. THE VIDEOS ARE HOSTED ON THE ASHP FOUNDATION WEBSITE AS A LEADERSHIP RESOURCE AND A SOURCE OF MOTIVATION FOR HEALTH-SYSTEM PHARMACY PROFESSIONALS. THREE NEW VIDEOS WERE ADDED TO THE COLLECTION IN 2012, BRINGING THE TOTAL TO 15 LEADER VIDEOS AND MP3 AUDIO VERSIONS. LEADERSHIP SPEAKERS BUREAU (LSB)-THE LSB IS THE FIRST PROGRAM OF THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP DEVELOPED SPECIFICALLY FOR STUDENTS. PHARMACISTS WHO ARE ASHP STATE AFFILIATE MEMBERS ARE THE PRIMARY SPEAKERS ALONG WITH PLA AND PLI ALUMNI. THEY DRAW UPON THEIR PERSONAL AND PROFESSIONAL EXPERIENCES TO ENCOURAGE STUDENTS TO EMBRACE LEADERSHIP AS PART OF THEIR PROFESSIONAL OBLIGATION. SPEAKERS HIGHLIGHT LEADERSHIP OPPORTUNITIES AND PRACTICE SUCCESS STORIES IN HEALTH-SYSTEM PHARMACY TO UNDERSCORE THE NEED FOR THIS COMMITMENT AS STUDENTS. THE STUDENT FORUM LEADERSHIP SECTION ADVISORY GROUP HAS BECOME AN ACTIVE PARTNER IN THE LSB'S PROMOTION AND EVALUATION. STUDENT LEADERSHIP DEVELOPMENT WORKSHOP-THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP WORKED WITH THE SECTION OF PHARMACY PRACTICE MANAGERS TO SUPPORT A SERIES OF 3-HOUR LEADERSHIP DEVELOPMENT WORKSHOPS FOR PHARMACY STUDENTS AT THREE ASHP STATE AFFILIATE MEETINGS. THE CENTER SUPPORTED 3 WORKSHOPS AND CONTINUES TO WORK WITH THE SECTION ON PHARMACY PRACTICE MANAGERS TO LOOK FOR OPPORTUNITIES TO MAKE THE WORKSHOPS SUSTAINABLE IN THE COMING YEARS. COMMUNITY HEALTH SYSTEMS (CHS) LEADERSHIP SEMINAR SERIES-IN FEBRUARY 2012, THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP LAUNCHED ITS THIRD OFFERING OF AN 8-MONTH LEADERSHIP SEMINAR SERIES FOR THE PHARMACISTS EMPLOYED BY CHS, THE NATION'S THIRD LARGEST HEALTH SYSTEM. THE CHS SENIOR PHARMACY LEADERSHIP TEAM HAS DEVELOPED A COLLABORATIVE WORKING RELATIONSHIP WITH THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP TO OFFER THIS PROGRAM WHICH IS CUSTOMIZED TO MEET THE UNIQUE LEADERSHIP NEEDS AND CHALLENGES FOR CHS PHARMACISTS ACROSS THE NATION. TOPICS INCLUDE LEADERSHIP SUBJECTS THAT HAVE BEEN PRESENTED IN PAST LEADERSHIP LEARNING COMMUNITIES SPONSORED BY THE CENTER AT THE ASHP SUMMER MEETING, AND ARE PRESENTED VIA LIVE, WEB-BASED DISTANCE LEARNING MECHANISMS. THE PROGRAM IS ADMINISTERED FROM FEBRUARY THROUGH NOVEMBER WITH A BREAK IN JULY AND AUGUST AND REACHES 175-200 STAFF PER MONTH. LEADERSHIP RESOURCE CENTER-SPONSORED BY BAXTER HEALTHCARE, INC., THIS PROGRAM WAS DEVELOPED IN 2009 AND LAUNCHED IN FEBRUARY OF 2010 AS A WEB-BASED RESOURCE THAT IS PART OF THE ASHP FOUNDATION'S WEBSITE. THE PRIMARY GOAL OF THE LEADERSHIP RESOURCE CENTER (LRC) IS TO HAVE AN ONGOING AND CONTINUOUSLY UPDATED SOURCE OF LEADERSHIP INFORMATION AND TOOLS TO ASSIST PHARMACISTS AT ALL STAGES OF THEIR CAREER. THE COMPONENT PARTS OF THE LRC INCLUDE: (1) A LEADERSHIP SELF-ASSESSMENT TOOL TO MEASURE ONE'S LEADERSHIP CAPABILITIES AND TO IDENTIFY AREAS FOR IMPROVEMENT, (2) A LEADER'S TOOL KIT THAT INCLUDES A HOST OF PRACTICAL RESOURCES THAT LEADERS CAN USE IN WORKING WITH TEAMS AND IN PLANNING PROJECTS, (3) A LEADERSHIP PRIMER WHICH SERVES AS AN EDUCATIONAL PROGRAM AND REFERENCE RESOURCE FOR LEADERSHIP DEVELOPMENT, AND (4) TWO EDUCATIONAL MODULE ENTITLED "LEADING FOR INFLUENCE AND ADVOCACY," WHICH IS DESIGNED TO HELP PHARMACISTS EXPAND THEIR INFLUENCE AND EFFECTIVENESS IN ADVANCING SAFE AND EFFECTIVE MEDICATION USE ON AN INSTITUTION-WIDE BASIS AND "CLINICAL MICROSYSTEMS: TRANSFORMATIONAL FRAMEWORK FOR LEAN THINKING." DIALOGUE WITH BAXTER HEALTHCARE CONTINUED IN FY12 TO EXPAND THE LRC. WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY-DESIGNED TO HONOR THE DISTINGUISHED 40-YEAR ASHP CAREER OF WILLIAM A. ZELLMER, THE ASHP FOUNDATION COMMITTED TO FUND AND CO-ADMINISTER AN ANNUAL LEADERSHIP LECTURE PROGRAM IN PARTNERSHIP WITH ASHP. THE ANNUAL LECTURE IS PRESENTED TO ASHP PRACTICE LEADERS WHO ATTEND THE ANNUAL ASHP POLICY WEEK IN SEPTEMBER AND FOCUSES ON ADDRESSING THE CHALLENGES OF ADVANCING PHARMACY PRACTICE WHILE NAVIGATING THE STATE AND FEDERAL POLICY LANDSCAPES.Description
FieldValueIRS element (for citing)
Total Program Service Expense3104305TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments1TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities0ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities1FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions1DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity1RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org1TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With109672NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees0NumberOfEmployees
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions1QuidProQuoContributions
Quid Pro Quo Disclosure1QuidProQuoDisclosure
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members12NbrVotingGoverningBodyMembers
Number Independent Voting Members10NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees0MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1ELIZABETH HARTNETTBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number3016648612TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line17272 WISCONSIN AVENUE 2ND FLOORAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (16 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorOfficerOfficerReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationHighest Compensated EmployeeHighestCompensatedEmployee
LYNNAE M MAHANEY MBA FASHP
CHAIR1.00XX000
DAVID R GAUGH
VICE CHAIR1.00XX000
HENRI R MANASSE JR PHD SCD
PRESIDENT (6/11-12/11)/ASHP EVP-CEO1.00XX075736179765
PHILIP J SCHNEIDER BS PHARMD
TREASURER1.00XX000
STEPHEN J ALLEN MS FASHP
SECRETARY/EVP-CEO40.00XX251988028841
BARBARA BALIK RN MS EDD
DIRECTOR AT LARGE1.00X000
MICK L HUNT MS MBA FASHP
DIRECTOR AT LARGE1.00X000
MICHAEL S FLAGSTAD MS RPH
DIRECTOR AT LARGE1.00X000
RANDALL A LIPPS BS BBA
DIRECTOR AT LARGE1.00X000
BRUCE E SCOTT PHARMD FASHP
DIRECTOR AT LARGE1.00X000
DIANE B GINSBURG MS FASHP
DIRECTOR AT LARGE1.00X0149240
GEORGE ZORICH PHARM BS
DIRECTOR AT LARGE1.00X000
PAUL W ABRAMOWITZ PHARMD
PRESIDENT (1/12-5/12)/ASHP EVP-CEO1.00XX000
DANIEL COBAUGH
VICE PRESIDENT40.00179594023727X
RICHARD WALLING
DIRECTOR, CTR FOR HLTH-SYS PHARM LDRSHP40.00150986014311X
MYRNA KONAJESKI
DIRECTOR OF DEVELOPMENT40.00107200026630X
FieldValueIRS element (for citing)
Total Reportable Comp From Org689768TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs772285TotalReportableCompFrmRltdOrgs
Total Other Compensation173274TotalOtherCompensation
Number Individuals GT100 K4NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation

Name Of Contractor NameOfContractor

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1GLOBALHEALTH EDUCATION & TRAINING LLCBusinessNameLine1

Address Of Contractor AddressOfContractor

Address US AddressUS

FieldValueIRS element (for citing)
Address Line13111 SOUTH DIXIE HWY SUITE 101AddressLine1
CityWEST PALM BEACHCity
StateFLState
ZIP Code33405ZIPCode
FieldValueIRS element (for citing)
Description Of ServicesCONTRACT SERVICESDescriptionOfServices
Compensation113704Compensation
FieldValueIRS element (for citing)
Number Of Contractors GT100 K1NumberOfContractorsGT100K
Fundraising Events130000FundraisingEvents
All Other Contributions2893671AllOtherContributions
Noncash Contributions38288NoncashContributions
Total Contributions3023671TotalContributions

Program Service Revenue ProgramServiceRevenue

FieldValueIRS element (for citing)
DescriptionPHARMACY LEADERSHIP ACDescription
Business Code900099BusinessCode
Total Revenue Column283495TotalRevenueColumn
Related Or Exempt Function Income283495RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Program Service Revenue283495TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column219336TotalRevenueColumn
Exclusion$219,336ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities2520284Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities2703065Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities-182781Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column-182781TotalRevenueColumn
Exclusion-$182,781ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events30000GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events130000CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses40941FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column-10941TotalRevenueColumn
Exclusion-$10,941ExclusionAmount

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column3332780TotalRevenueColumn
Related Or Exempt Function Income283495RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$25,614ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total1262825Total
Program Services1262825ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total106324Total
Program Services106324ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total283683Total
Program Services193363ProgramServices
Management And General12734ManagementAndGeneral
Fundraising77586Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total740946Total
Program Services507947ProgramServices
Management And General27741ManagementAndGeneral
Fundraising205258Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total100676Total
Program Services68178ProgramServices
Management And General7828ManagementAndGeneral
Fundraising24670Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total67240Total
Program Services42635ProgramServices
Management And General4887ManagementAndGeneral
Fundraising19718Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total56627Total
Program Services45417ProgramServices
Management And General4139ManagementAndGeneral
Fundraising7071Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total9980Total
Management And General9980ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total728879Total
Program Services593390ProgramServices
Management And General40033ManagementAndGeneral
Fundraising95456Fundraising

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total33650Total
Program Services10235ProgramServices
Management And General2090ManagementAndGeneral
Fundraising21325Fundraising

Occupancy Occupancy

FieldValueIRS element (for citing)
Total65150Total
Program Services35832ProgramServices
Management And General13682ManagementAndGeneral
Fundraising15636Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total214230Total
Program Services174014ProgramServices
Management And General33566ManagementAndGeneral
Fundraising6650Fundraising

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total16611Total
Program Services12900ProgramServices
Management And General3711ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
GENERAL EXPENSES10672586174484315708
TEMPORARY SERVICES726758134361018
BANK FEES30933093
STAFF DEVELOPMENT516199317

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total-40941Total
Program Services-40941ProgramServices

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total3763481Total
Program Services3104305ProgramServices
Management And General168763ManagementAndGeneral
Fundraising490413Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY2073427BOY
EOY1739986EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY197662BOY
EOY233990EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY1847BOY
EOY4339EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis110829LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec98560LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY28879BOY
EOY12269EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY9058798BOY
EOY8781502EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY121588BOY
EOY93145EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY11482201BOY
EOY10865231EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY182577BOY
EOY204503EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY152829BOY
EOY180141EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY54285BOY
EOY55299EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY389691BOY
EOY439943EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY2060723BOY
EOY1237683EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY4253393BOY
EOY4409211EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY4778394BOY
EOY4778394EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY11092510BOY
EOY10425288EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY11482201BOY
EOY10865231EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-430701ReconcilationRevenueExpenses
Reconcilation Other Changes-236521ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee0AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org170b1 AviXPubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1802114CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years1610656CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years1993575CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2697502CurrentTaxYearMinus1Year
Current Tax Year3023671CurrentTaxYear
Total11127518Total

Total170 Total170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years1802114CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years1610656CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years1993575CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year2697502CurrentTaxYearMinus1Year
Current Tax Year3023671CurrentTaxYear
Total11127518Total
FieldValueIRS element (for citing)
Amounts Subst Contributors Total5604013AmountsSubstContributorsTotal
Public Support Total1705523505PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years307359CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years299628CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years234578CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year232970CurrentTaxYearMinus1Year
Current Tax Year219291CurrentTaxYear
Total1293826Total

Other Income170 OtherIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years6720CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years9285CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years8760CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year7085CurrentTaxYearMinus1Year
Current Tax Year30000CurrentTaxYear
Total61850Total
FieldValueIRS element (for citing)
Total Support12483194TotalSupport
Gross Receipts From Admissions Etc850844GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage1700.44250PublicSupportPertcentage170
Public Support Pertcent Prior Year0.45060PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170XThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule D IRS990ScheduleD

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance6281196BeginningOfYearBalance
Contributions0Contributions
Investment Earnings Or Losses-174945InvestmentEarningsOrLosses
Other Expenditures42929OtherExpenditures
End Of Year Balance6063322EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance5934328BeginningOfYearBalance
Contributions350Contributions
Investment Earnings Or Losses886373InvestmentEarningsOrLosses
Other Expenditures539855OtherExpenditures
End Of Year Balance6281196EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

FieldValueIRS element (for citing)
Beginning Of Year Balance5554292BeginningOfYearBalance
Contributions7295Contributions
Investment Earnings Or Losses899095InvestmentEarningsOrLosses
Other Expenditures526354OtherExpenditures
End Of Year Balance5934328EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

FieldValueIRS element (for citing)
Beginning Of Year Balance6505305BeginningOfYearBalance
Contributions900Contributions
Investment Earnings Or Losses-1659001InvestmentEarningsOrLosses
Other Expenditures-707088OtherExpenditures
End Of Year Balance5554292EndOfYearBalance
FieldValueIRS element (for citing)
Board Designated EOY Balance0.08250BoardDesignatedEOYBalance
Permanent Endowment EOY Balance0.78810PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.12940TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs0EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs0EndowmentsHeldByRelatedOrgs

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis110829OtherCostOrOtherBasis
Depreciation98560Depreciation
Book Value12269BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings12269TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
DescriptionDUE TO ASHPDescription
Amount$55,299Amount
FieldValueIRS element (for citing)
Total Of Amounts55299TotalOfAmounts
Total Revenue3332780TotalRevenue
Total Expenses3763481TotalExpenses
Excess Or Deficit For Year-430701ExcessOrDeficitForYear
Net Unrealized GL On Investments-236521NetUnrealizedGLOnInvestments
Total Adjustments-236521TotalAdjustments
Excess Or Deficit Per FS-667222ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt3190963TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments-236521NetUnrealizedGainsInvestments
Donated Srvc And Use Of Facilities53763DonatedSrvcAndUseOfFacilities
Other Revenues40941OtherRevenues
Revenue Not Rptd F990-141817RevenueNotRptdF990
Revenue Subtotal3332780RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form9903332780TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt3858185TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities53763DonatedServicesUseOfFacilities
Other Expenses Included40941OtherExpensesIncluded
Expenses Not Rptd F99094704ExpensesNotRptdF990
Expenses Subtotal3763481ExpensesSubtotal
Expenses Not Rptd On Fin Stmt0ExpensesNotRptdOnFinStmt
Total Expenses Per Form9903763481TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:PART V, LINE 4:THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:PART X:DURING THE YEAR ENDED MAY 31, 2012, MANAGEMENT DID NOT IDENTIFY ANY UNCERTAIN INCOME TAX POSITIONS. AT A MINIMUM, THE TAX YEARS BEGINNING IN 2008 THROUGH 2011 ARE OPEN FOR EXAMINATION BY TAX AUTHORITIES.
PART XII, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE REPORTED IN PART VIII 40,941.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:SPECIAL EVENTS EXPENSE REPORTED IN PART VIII 40,941.

Schedule G IRS990ScheduleG

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1MANASSE DINNERNameOfEvent1
Gross Receipts Event1160000GrossReceiptsEvent1
Charitable Contributions Event1130000CharitableContributionsEvent1
Gross Revenue Event130000GrossRevenueEvent1
Rent Facility Costs Event133808RentFacilityCostsEvent1
Other Direct Expenses Event17133OtherDirectExpensesEvent1
Gross Receipts Total160000GrossReceiptsTotal
Charitable Contributions Total130000CharitableContributionsTotal
Gross Revenue Total Events30000GrossRevenueTotalEvents
Rent Facility Costs Total Events33808RentFacilityCostsTotalEvents
Other Direct Expenses Total Events7133OtherDirectExpensesTotalEvents
Direct Expense Summary Events40941DirectExpenseSummaryEvents
Net Income Summary-10941NetIncomeSummary

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (46 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantAddress Line2AddressUS/AddressLine2
ALLINA HOSPITALS AND CLINICS
PO BOX 43MINNEAPOLISMN55440363261413501(C)(3)133012009 MEDICATION SAFETY GRANT
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
7272 WISCONSIN AVEBETHESDAMD20814520807628501(C)(6)74018CLINICAL SKILLS GRANT, LEADERSHIP CONFERENCE
AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION
1 CHURCH ST STE 202ROCKVILLEMD20850530214882501(C)(3)5500SPONSORSHIP FOR 2011
BOARD OF REGENTS UNIV OF WISCONSIN
1220 LINDEN DRMADISONWI53706396006492501(C)(3)6279FEDERAL SERVICES RESEARCH GRANT
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115042312909501(C)(3)66032010 JR. INVESTIGATOR RESEARCH GRANT
FAIRVIEW HEALTH SERVICES
2450 RIVERSIDE AVEMINNEAPOLISMN55454410991680501(C)(3)40000EXPANSION GRANT
KAISER FOUNDATION HEALTH PLAN OF COLORADO
16601 E CENTRETECH PKWYAURORACO800119045840591617501(C)(3)248702011 AWARD FOR EXCELLENCE, 2010 JR. INVESTING GRANT, PPMI DEMO GRANT
FROEDTERT HEALTH SERVICES
9200 W WISCONSIN AVEMILWAUKEEWI53226392014409501(C)(3)40000EXPANSION GRANT
THE GENEVA FOUNDATION
917 PACIFIC AVE STE 600TACOMAWA98402911593913501(C)(3)40000EXPANSION GRANT
HARRIS COUNTY HOSPITAL DISTRICT FOUNDATION
2525 HOLLY HALL STHOUSTONTX77054760408224501(C)(3)40000EXPANSION GRANT
MASSACHUSETTS COLLEGE OF PHARMACY
179 LONGWOOD AVEBOSTONMA02115042104700501(C)(3)166672009 FEDERAL SERVICES JR. INVESTIGATOR GRANT
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905416011702501(C)(3)170002009 EMERGENCY CARE GRANT
METHODIST HOSPITALS OF DALLAS
1441 N BECKLEY AVEDALLASTX75203750800661501(C)(3)40000EXPANSION GRANT
MIAMI VA HEALTHCARE SYSTEM
1201 1NW 16TH STMIAMIFL33125562304427501(C)(3)40000EXPANSION GRANT
TENNESSEE VALLEY HEALTH CARE SYSTEMMIDDLE TENN RES INSTITUTE
1310 24TH AVE SNASHVILLETN37212621387860501(C)(3)74672010 FEDERAL SERVICES JR. INVESTIGATOR GRANT
UNIVERSITY OF IOWA
4 JESSUP HALLIOWAS CITYIA52242426004813501(C)(3)136002009 MEDICATION SAFETY TEAM GRANT
UNIVERSITY OF MARYLAND BALTIMORE
620 W LEXINGTON STBALTIMOREMD21201526002033501(C)(3)167502010 PROMOTING INFLUENZA PREVENTION GRANT
UNIVERSITY OF ROCHESTER MEDICAL CENTER
601 ELMWOOD AVEROCHESTERNY14642160743209501(C)(3)170002009 EMERGENCY CARE GRANT
WEST VIRGINIA UNIVERSITY HOSPITAL
1 MEDICAL CENTER DRMORGANTOWNWV26506550643304501(C)(3)82502011 JR. INVESTIGATOR GRANT
WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION
886 CHESTNUT RIDGE RD RM723MORGANTOWNWV26505550665758501(C)(3)167502010 PROMOTING INFLUENZA PREVENTION GRANT
ADVOCATE HEALTH AND HOSPITALS CORPORATION
2025 WINDSOR DROAK BROOKIL60523362169147501(C)(3)40000EXPANSION GRANT
ASPIRUS WAUSAU HOSPITAL INC
2333 PINE RIDGE BLVDWAUSAUWI54401391138241501(C)(3)40000EXPANSION GRANT
HARTFORD HOSPITAL
PO BOX 5037HARTFORDCT06102060646668501(C)(3)66492011 JR. INVESTIGATOR GRANT
HENRY FORD HEALTH SYSTEM
ONE FORD PL - STE 5FDETROITMI48202381357020501(C)(3)50002011 PHARM RESID GRANT
IHC HEALTH SERVICES
36 S STATE ST STE 1000SALT LAKE CITYUT84111942854057501(C)(3)40000EXPANSION GRANT
INDIANA UNIVERSITY HEALTH INC
950 N MERIDIAN ST STE 1200INDIANAPOLISIN46204351955872501(C)(3)50002011 PHARM. RESIDENT PRACTICE
INSTITUTIONAL PROF PRAC EDUCATION FUND
410 W 10TH AVENUECOLUMBUSOH43210316025986501(C)(3)40000EXPANSION GRANT
JOHNS HOPKINS BAYVIEW MEDICAL CENTER INC
3910 KESWICK RD SOUTH BLDG 4THBALTIMOREMD21211521341890501(C)(3)40000EXPANSION GRANTFLOOR
LOMA LINDA UNIVERSITY
PO BOX 2000LOMA LINDACA92354951816009501(C)(3)40000EXPANSION GRANT
LUCILE SALTER PACKARD CHILDREN'S HOSPITAL
725 WELCH RDPALO ALTOCA94304770003859501(C)(3)40000EXPANSION GRANT
MORTON PLANT MEASE HEALTH CARE FOUNDATION INC
1200 DRUID ROAD SOUTHCLEARWATERFL33756591751535501(C)(3)5000PHARMACY RESIDENT PRACTICE
NORMAN REGIONAL HEALTH SYSTEM
700 S TELEPHONE RDMOOREOK73160731203942501(C)(3)40000EXPANISON GRANT
NORTHWESTERN MEMORIAL HOSPITAL
676 N ST CLAIRCHICAGOIL60611370960170501(C)(3)8250PRACTICE MODEL GRANT
PRINCETON BAPTIST MEDICAL CENTER
701 PRINCETON AVE SWBIRMINGHAMAL35211630869488501(C)(3)40000EXPANSION GRANT
REGENTS OF THE UNIVERSITY OF MICHIGAN
PO BOX 130047ANN ARBORMI48113386006309501(C)(3)100002011 AWARD FOR EXCELLENCE
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT DAVIS
ONE SHIELDS AVEDAVISCA95616946036494501(C)(3)40000EXPANSION GRANT
ST LOUIS COLLEGE OF PHARMACY
4588 PARKVIEW PLACEST LOUISMO63110430652675501(C)(3)40000EXPANSION GRANT
TRUMAN MEDICAL CENTER
2301 HOLMES STKANSAS CITYMO64108440661018501(C)(3)40000EXPANSION GRANT
UNIVERSITY OF ARIZONA
PO BOX 3308TUCSONAZ85722742652689501(C)(3)82502011 PROMOTING INFLUENZA PREVENTION GRANT
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
301 PETERSON SERVICE BUILDINGLEXINGTONKY40506616033693501(C)(3)118142007 FED SERVICES JR. INVESTIGATOR, 2011 PHARM RESIDENCY GRANT
UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION
22 S GREENE STBALTIMOREMD21201521362793501(C)(3)40000EXPANSION GRANT
UNIVERSITY OF PITTSBURGH
107 CATHEDRAL OF LEARNING 4200PITTSBURGHPA15260250965591501(C)(3)74575CONTINUITY OF CARE GRANT, JR. INVESTIGATORFIFTH AVENUE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER PRESBYTERIAN SHADYSIDE
600 GRANT ST FL 56PITTSBURGHPA15219250965480501(C)(3)40000EXPANSION GRANT
UNIVERSITY OF WISCONSIN FOUNDATION
1848 UNIVERSITY AVEMADISONWI53726390743975501(C)(3)50000AWARD FOR EXCELLENCE GRANT
WAYNE STATE
5700 CASS AVENUE STE 4900DETROITMI48202386028429501(C)(3)8250PHARMACY PRACTICE MODEL GRANT
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT SF
521 PARNASSUS AVESAN FRANCISCOCA941430622946036493501(C)(3)6600JR. INVESTIGATOR GRANT
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants45TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations1TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII (8 entries)

Type Of GrantTypeOfGrantNumber Of RecipientsNumberOfRecipientsAmount Of Cash GrantAmountOfCashGrant
LITERATURE AWARDS PROGRAM717274
STUDENT LEADERSHIP AWARDS1230000
EXCELLENCE AWARDS55000
INSULIN USE SAFETY HONORARIUM1517000
PPMICS TOOL HONORARIUM1215250
PHARM RESID EXCELLENCE PANEL72800
PPMI WEBINAR HONORARIUM167000
ENVIRONMENTAL FORECASTING PROJECT612000

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeXCompensationCommittee
Form990 Of Other OrganizationsXForm990OfOtherOrganizations
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (4 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
HENRI R MANASSE JR PHD SCD
0695040030000032321063172023203084373600
STEPHEN J ALLEN MS FASHP
2261830150000108050216260100690283683000
DANIEL COBAUGH
1705820847605360165120101810206287000
RICHARD WALLING
1406040684803534013498017640166248000

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTraded

FieldValueIRS element (for citing)
Non Cash CheckboxXNonCashCheckbox
Number Of Contributions1NumberOfContributions
Noncash Contribs Rptd F99038288NoncashContribsRptdF990
Method Of Determining RevenuesCASH SALE VALUEMethodOfDeterminingRevenues
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGifts
Third Parties Used0ThirdPartiesUsed

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (8 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 2BUSINESS RELATIONSHIP - MICHAEL S. FLAGSTAD AND LYNNAE M. MAHANEY.
FORM 990, PART VI, SECTION A, LINE 7ATHREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
FORM 990, PART VI, SECTION A, LINE 8BTHERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 12CANNUALLY AT THE MARCH MEETING
FORM 990, PART VI, SECTION B, LINE 15ACEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.
FORM 990, PART VI, SECTION C, LINE 19THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 5:NET UNREALIZED LOSSES ON INVESTMENTS: -236,521.CHANGES IN NET ASSETS OR FUND BALANCES:

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEINEINPrimary ActivitiesPrimaryActivitiesLegal Domicile StateLegalDomicileStateExempt Code SectionExemptCodeSectionDirect Controlling Entity NADirectControllingEntityNAControlled OrgControlledOrgBusiness Name Line1DirectControllingEntityName/BusinessNameLine1
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)
7272 WISCONSIN AVENUEBETHESDAMD20814520807628TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSIONMD501(C)(6)N/A0
7272 WISCONSIN BUILDING CORPORATION
7272 WISCONSIN AVENUEBETHESDAMD20814521760057TITLE HOLDING COMPANYMD501(C)(2)0AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
FieldValueIRS element (for citing)
Receipt Of Int Ann Rents Royalties0ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org1GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org1GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org0LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org0SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org0PurchaseOfAssetsFromOtherOrg
Exchange Of Assets0ExchangeOfAssets
Rental Of Facilities To Other Orgs0RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs0RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs0PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs0PerformOfServicesByOtherOrgs
Sharing Of Facilities1SharingOfFacilities
Sharing Of Paid Employees1SharingOfPaidEmployees
Reimbursement Paid To Other Org1ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrg
Other Transfer To Other Org0OtherTransferToOtherOrg
Other Transfer From Other Org1OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (6 entries)

Transaction TypeTransactionTypeAmount InvolvedAmountInvolvedMethod Of Amt DeterminationMethodOfAmtDetermination
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
O1499743RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
M507842RECORDED EXPENSES
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
R991901CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
C891169CASH
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
N53763FAIR VALUE
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
B74018CASH

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.